| Trial ID: | L0237 |
| Source ID: | NCT00438932
|
| Associated Drug: |
Lanthanum Carbonate
|
| Title: |
Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00438932/results
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Lanthanum Carbonate|DIETARY_SUPPLEMENT: Low Phosphorus Diet|DIETARY_SUPPLEMENT: Unrestricted Phosphorus Diet|DRUG: Placebo
|
| Outcome Measures: |
Primary: Fibroblast Growth Factor 23 (FGF-23), Plasma FGF-23 was measured using c-terminal FGF23 assay., 2 weeks | Secondary: 24-hour Urinary Phosphate, from 24-hr urine collections, 2 weeks
|
| Sponsor/Collaborators: |
Sponsor: Massachusetts General Hospital | Collaborators: Shire
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
|
| Start Date: |
2007-01
|
| Completion Date: |
2010-01
|
| Results First Posted: |
2011-09-27
|
| Last Update Posted: |
2011-09-27
|
| Locations: |
Massachusetts General Hospital, Boston, Massachusetts, 02114, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00438932
|
